Ovid Therapeutics Inc (OVID)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $479.38M
Last updated: Nov 17, 2026 at 4:33 PM ET
Ovid Therapeutics Inc (OVID) Stock Chart
Ovid Therapeutics (OVID) has a latest price of $2.22 on Nov 17, 2026, 28.5% below its 52-week high of $3.10. Its price rose 70.1% over the past 12 months. The month-end price fell 80.1% since May 2017, a compound annual decline of 15.7%.
Price Chart
From May 2017 to Oct 2026, its highest month-end close was $12.75 in May 2017 and its lowest $0.27 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OVID with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OVID.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 24.2%, and over 6 months it fell 7.5%. The month-end price fell 28.5% over the 3 years through Oct 2026, a compound annual decline of 10.6%.
| Period | Change |
|---|---|
| 1 month | +2.3% |
| 3 months | -24.2% |
| 6 months | -7.5% |
| 12 months | +70.1% |
| 12 months, with dividends | +70.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -28.5% | -10.6% |
| 5 years | -25.3% | -5.7% |
| Since May 2017 | -80.1% | -15.7% |
Price by Year
Its best calendar year was 2025, when the price rose 74.6%, and its weakest was 2018, when it fell 75.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.54 | +55.8% |
| 2025 | $1.63 | +74.6% |
| 2024 | $0.93 | -71.0% |
| 2023 | $3.22 | +73.1% |
| 2022 | $1.86 | -42.1% |
| 2021 | $3.21 | +39.0% |
| 2020 | $2.31 | -44.3% |
| 2019 | $4.15 | +71.5% |
| 2018 | $2.42 | -75.5% |
Trading Range
The price is 10.8% below its 50-day average of $2.49 and 8.3% below its 200-day average of $2.42.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.22 | |
| 52-week high | $3.10 | -28.5% |
| 52-week low | $1.21 | +83.5% |
| 50-day average | $2.49 | -10.8% |
| 200-day average | $2.42 | -8.3% |
Price Risk
Over 3 years, its largest fall from a peak was 93.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.46 |
| Largest fall, 1 year | -27.4% |
| Largest fall, 3 years | -93.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OVID
What is OVID's 1-year price change?
Ovid Therapeutics's price rose 70.1% over the past 12 months. With dividends included, the 12-month total return was 70.1%.
What is OVID's 5-year price change?
Ovid Therapeutics's month-end price fell 25.3% over the 5 years through Oct 2026, a compound annual decline of 5.7%. These figures leave out dividends.
What is OVID's 52-week high and low?
Ovid Therapeutics's 52-week high is $3.10 and its 52-week low is $1.21. Its latest price of $2.22 on Nov 17, 2026 is 28.5% below the high.
What is OVID's beta?
Ovid Therapeutics's 1-year beta against the S&P 500 is 1.46, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 27.4%.
Is the OVID chart free?
Yes. Advanced Charting for OVID is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OVID pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors